141 related articles for article (PubMed ID: 12757728)
1. Bisquaternary dimers of strychnine and brucine. A new class of potent enhancers of antagonist binding to muscarinic M2 receptors.
Zlotos DP; Buller S; Holzgrabe U; Mohr K
Bioorg Med Chem; 2003 Jun; 11(12):2627-34. PubMed ID: 12757728
[TBL] [Abstract][Full Text] [Related]
2. Allosteric interactions of quaternary strychnine and brucine derivatives with muscarinic acetylcholine receptors.
Gharagozloo P; Lazareno S; Popham A; Birdsall NJ
J Med Chem; 1999 Feb; 42(3):438-45. PubMed ID: 9986715
[TBL] [Abstract][Full Text] [Related]
3. Probing the pharmacophore for allosteric ligands of muscarinic M2 receptors: SAR and QSAR studies in a series of bisquaternary salts of caracurine V and related ring systems.
Zlotos DP; Buller S; Stiefl N; Baumann K; Mohr K
J Med Chem; 2004 Jul; 47(14):3561-71. PubMed ID: 15214783
[TBL] [Abstract][Full Text] [Related]
4. Allosteric site in M2 acetylcholine receptors: evidence for a major conformational change upon binding of an orthosteric agonist instead of an antagonist.
Grossmüller M; Antony J; Tränkle C; Holzgrabe U; Mohr K
Naunyn Schmiedebergs Arch Pharmacol; 2006 Jan; 372(4):267-76. PubMed ID: 16362429
[TBL] [Abstract][Full Text] [Related]
5. Allosteric effects of four stereoisomers of a fused indole ring system with 3H-N-methylscopolamine and acetylcholine at M1-M4 muscarinic receptors.
Lazareno S; Birdsall B; Fukazawa T; Gharagozloo P; Hashimoto T; Kuwano H; Popham A; Sugimoto M; Birdsall NJ
Life Sci; 1999; 64(6-7):519-26. PubMed ID: 10069518
[TBL] [Abstract][Full Text] [Related]
6. Subtype-selective positive cooperative interactions between brucine analogues and acetylcholine at muscarinic receptors: radioligand binding studies.
Lazareno S; Gharagozloo P; Kuonen D; Popham A; Birdsall NJ
Mol Pharmacol; 1998 Mar; 53(3):573-89. PubMed ID: 9495826
[TBL] [Abstract][Full Text] [Related]
7. M2 Subtype preferring dibenzodiazepinone-type muscarinic receptor ligands: Effect of chemical homo-dimerization on orthosteric (and allosteric?) binding.
Keller M; Tränkle C; She X; Pegoli A; Bernhardt G; Buschauer A; Read RW
Bioorg Med Chem; 2015 Jul; 23(14):3970-90. PubMed ID: 25650309
[TBL] [Abstract][Full Text] [Related]
8. Subtype-selective positive cooperative interactions between brucine analogs and acetylcholine at muscarinic receptors: functional studies.
Birdsall NJ; Farries T; Gharagozloo P; Kobayashi S; Lazareno S; Sugimoto M
Mol Pharmacol; 1999 Apr; 55(4):778-86. PubMed ID: 10101037
[TBL] [Abstract][Full Text] [Related]
9. Interactions between allosteric modulators and 4-DAMP and other antagonists at muscarinic receptors: potential significance of the distance between the N and carboxyl C atoms in the molecules of antagonists.
Lysíková M; Havlas Z; Tucek S
Neurochem Res; 2001 Apr; 26(4):383-94. PubMed ID: 11495349
[TBL] [Abstract][Full Text] [Related]
10. Modes of allosteric interactions with free and [3H]N-methylscopolamine-occupied muscarinic M2 receptors as deduced from buffer-dependent potency shifts.
Schröter A; Tränkle C; Mohr K
Naunyn Schmiedebergs Arch Pharmacol; 2000 Dec; 362(6):512-9. PubMed ID: 11138843
[TBL] [Abstract][Full Text] [Related]
11. Asparagine, valine, and threonine in the third extracellular loop of muscarinic receptor have essential roles in the positive cooperativity of strychnine-like allosteric modulators.
Jakubík J; Krejcí A; Dolezal V
J Pharmacol Exp Ther; 2005 May; 313(2):688-96. PubMed ID: 15647330
[TBL] [Abstract][Full Text] [Related]
12. Identification of a [3H]Ligand for the common allosteric site of muscarinic acetylcholine M2 receptors.
Tränkle C; Mies-Klomfass E; Cid MH; Holzgrabe U; Mohr K
Mol Pharmacol; 1998 Jul; 54(1):139-45. PubMed ID: 9658199
[TBL] [Abstract][Full Text] [Related]
13. Determinants of positive cooperativity between strychnine-like allosteric modulators and N-methylscopolamine at muscarinic receptors.
Jakubík J; Dolezal V
J Mol Neurosci; 2006; 30(1-2):111-2. PubMed ID: 17192652
[TBL] [Abstract][Full Text] [Related]
14. Allosteric interactions of staurosporine and other indolocarbazoles with N-[methyl-(3)H]scopolamine and acetylcholine at muscarinic receptor subtypes: identification of a second allosteric site.
Lazareno S; Popham A; Birdsall NJ
Mol Pharmacol; 2000 Jul; 58(1):194-207. PubMed ID: 10860942
[TBL] [Abstract][Full Text] [Related]
15. Muscarinic allosteric enhancers of ligand binding: pivotal pharmacophoric elements in hexamethonio-type agents.
Muth M; Sennwitz M; Mohr K; Holzgrabe U
J Med Chem; 2005 Mar; 48(6):2212-7. PubMed ID: 15771463
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological characterisation of strychnine and brucine analogues at glycine and alpha7 nicotinic acetylcholine receptors.
Jensen AA; Gharagozloo P; Birdsall NJ; Zlotos DP
Eur J Pharmacol; 2006 Jun; 539(1-2):27-33. PubMed ID: 16687139
[TBL] [Abstract][Full Text] [Related]
17. Using a radioalloster to test predictions of the cooperativity model for gallamine binding to the allosteric site of muscarinic acetylcholine M(2) receptors.
Tränkle C; Weyand O; Schröter A; Mohr K
Mol Pharmacol; 1999 Nov; 56(5):962-5. PubMed ID: 10531401
[TBL] [Abstract][Full Text] [Related]
18. New insight into active muscarinic receptors with the novel radioagonist [³H]iperoxo.
Schrage R; Holze J; Klöckner J; Balkow A; Klause AS; Schmitz AL; De Amici M; Kostenis E; Tränkle C; Holzgrabe U; Mohr K
Biochem Pharmacol; 2014 Aug; 90(3):307-19. PubMed ID: 24863257
[TBL] [Abstract][Full Text] [Related]
19. Heterotropic cooperativity within and between protomers of an oligomeric M(2) muscarinic receptor.
Shivnaraine RV; Huang XP; Seidenberg M; Ellis J; Wells JW
Biochemistry; 2012 Jun; 51(22):4518-40. PubMed ID: 22551249
[TBL] [Abstract][Full Text] [Related]
20. Utility of an "Allosteric Site-Impaired" M
Moo EV; Sexton PM; Christopoulos A; Valant C
Mol Pharmacol; 2018 Nov; 94(5):1298-1309. PubMed ID: 30213802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
